Studies have shown that high expression of SHMT2 may promote tumor proliferation in bladder cancer, rhabdomyosarcoma, esophageal cancer and diffuse large B-cell lymphoma [14, 22–24]. This evidence concerns the gene SHMT2 and esophageal cancer.